Abstract
Transgenic mice with cardiac specific overexpression of β-adrenergic receptor kinase-1 (βARK-1) exhibit reduced contractility in the presence of adrenergic stimulation. However, whether contractility is altered in the absence of exogenous agonist is not clear. Effects of βARK-1 overexpression on contraction were examined in mouse ventricular myocytes, studied at 37°C, in the absence of adrenergic stimulation. In myocytes voltage-clamped with microelectrodes (18–26 MΩ; 2.7 M KCl) to minimize intracellular dialysis, contractions were significantly larger in βARK-1 cells than in wild-type myocytes. In contrast, when cells were dialyzed with patch pipette solution (1–3 MΩ; 0 mM NaCl, 70 mM KCl, 70 mM potassium aspartate, 4 mM MgATP, 1 mM MgCl2, 2.5 mM KH2PO4, 0.12 mM CaCl2, 0.5 mM EGTA, and 10 mM HEPES), the extent of cell shortening was similar in wild-type and βARK-1 myocytes. Furthermore, when cells were dialyzed with solutions that contained phosphodiesterase-sensitive sodium-cAMP (50 μM), the extent of cell shortening was similar in wild-type and βARK-1 myocytes. However, when patch solutions were supplemented with phosphodiesterase-resistant 8-bromo-cAMP (50 μM), contractions were larger in βARK-1 than wild-type cells. This difference was eliminated by the protein kinase A inhibitor N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89). Interestingly, Ca2+ current amplitudes and inactivation rates were similar in βARK-1 and wild-type cells in all experiments. These results suggest components of the adenylyl cyclase-protein kinase A pathway are sensitized by chronically increased βARK-1 activity, which may augment contractile function in the absence of exogenous agonist. Thus, changes in contractile function in myocytes from failing hearts may reflect, in part, effects of chronic up-regulation of βARK-1 on the cAMP-protein kinase A pathway.
- Received May 15, 2006.
- Accepted August 31, 2006.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|